ArticleEye (London, England)2025

Infographic: therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial.

Sam Sherratt-Mayhew et al.PubMed ↗Publisher ↗

No numbers read from the abstract.